| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | SAMD1 URI1 CENPB YBX1 MYOD1 INSM1 RELA CAMTA2 MBD6 SKI ZNF750 TNRC18 ELK1 TAL1 BAHCC1 | 5.08e-06 | 739 | 102 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | NR2E3 MYOD1 RELA E4F1 IRX3 MESP1 RAX2 RFX2 RFXAP ZNF750 ELK1 | 1.36e-04 | 560 | 102 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | NR2E3 MYOD1 RELA E4F1 IRX3 MESP1 RAX2 RFX2 RFXAP ZNF750 ELK1 | 1.49e-04 | 566 | 102 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NR2E3 FOXQ1 UNCX MYOD1 INSM1 RELA E4F1 IRX3 MESP1 SKI RAX2 RFX2 RFXAP IRX4 ZNF750 DMRTB1 ELK1 TAL1 | 2.66e-04 | 1412 | 102 | 18 | GO:0000981 |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 3.46e-04 | 27 | 102 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NR2E3 FOXQ1 MYOD1 INSM1 RELA E4F1 IRX3 MESP1 SKI RAX2 RFX2 IRX4 ZNF750 DMRTB1 ELK1 TAL1 | 5.52e-04 | 1244 | 102 | 16 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NR2E3 FOXQ1 MYOD1 INSM1 RELA E4F1 IRX3 MESP1 SKI RAX2 RFX2 IRX4 ZNF750 DMRTB1 ELK1 TAL1 | 6.97e-04 | 1271 | 102 | 16 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NR2E3 FOXQ1 MYOD1 INSM1 RELA E4F1 IRX3 MESP1 SKI RAX2 RFX2 RFXAP IRX4 ZNF750 DMRTB1 ELK1 TAL1 | 1.11e-03 | 1459 | 102 | 17 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.28e-03 | 320 | 102 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.42e-03 | 326 | 102 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | JUN kinase kinase kinase activity | 1.65e-03 | 12 | 102 | 2 | GO:0004706 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NR2E3 YBX1 MYOD1 EGLN1 MAML1 SUPT20HL2 RELA E4F1 CAMTA2 IRX3 MESP1 SKI RAX2 RFX2 RFXAP MAP3K1 ZNF750 BMP6 ELK1 MAPK7 TAL1 SERTAD1 | 7.79e-07 | 1390 | 101 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | CDKN1C ZNF703 SAMD1 NR2E3 URI1 FOXQ1 YBX1 INSM1 GON4L RELA E4F1 IRX3 MESP1 SKI IRX4 ZNF750 BMP6 ZNF469 TAL1 SDCBP | 1.24e-05 | 1399 | 101 | 20 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CDKN1C SAMD1 NR2E3 URI1 FOXQ1 YBX1 INSM1 RELA E4F1 IRX3 SKI IRX4 ZNF750 BMP6 ZNF469 TAL1 SDCBP | 1.32e-05 | 1053 | 101 | 17 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | CDKN1C ZNF703 SAMD1 NR2E3 URI1 FOXQ1 YBX1 INSM1 GON4L RELA E4F1 IRX3 MESP1 SKI IRX4 ZNF750 BMP6 ZNF469 TAL1 SDCBP | 1.44e-05 | 1413 | 101 | 20 | GO:1902679 |
| GeneOntologyBiologicalProcess | response to growth factor | CDKN1C ZNF703 URI1 PEG10 RELA SKI ADGRA2 MAP3K1 BMP6 BMP8B ELK1 BMP8A MAPK7 SDCBP HSPB1 | 2.52e-05 | 883 | 101 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | cartilage development | 2.60e-05 | 243 | 101 | 8 | GO:0051216 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.07e-05 | 336 | 101 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.77e-05 | 343 | 101 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 6.41e-05 | 276 | 101 | 8 | GO:0007179 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | CDKN1C ZNF703 URI1 PEG10 RELA SKI ADGRA2 MAP3K1 BMP6 BMP8B BMP8A MAPK7 SDCBP HSPB1 | 6.72e-05 | 850 | 101 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | skeletal system development | CDKN1C UNCX RELA SKI IDUA PTH1R MEX3C BMP6 BMP8B DCHS1 BMP8A | 2.12e-04 | 615 | 101 | 11 | GO:0001501 |
| Domain | IRO | 4.45e-04 | 6 | 103 | 2 | SM00548 | |
| Domain | Iroquois_homeo | 4.45e-04 | 6 | 103 | 2 | IPR003893 | |
| Domain | TGFb_propeptide | 4.83e-04 | 28 | 103 | 3 | PF00688 | |
| Domain | TGF-b_N | 4.83e-04 | 28 | 103 | 3 | IPR001111 | |
| Domain | Homeodomain-like | 5.04e-04 | 332 | 103 | 8 | IPR009057 | |
| Domain | TIG | 6.54e-04 | 31 | 103 | 3 | PF01833 | |
| Domain | Sema | 6.54e-04 | 31 | 103 | 3 | SM00630 | |
| Domain | Semap_dom | 6.54e-04 | 31 | 103 | 3 | IPR001627 | |
| Domain | Sema | 6.54e-04 | 31 | 103 | 3 | PF01403 | |
| Domain | SEMA | 6.54e-04 | 31 | 103 | 3 | PS51004 | |
| Domain | TGF-beta-rel | 7.19e-04 | 32 | 103 | 3 | IPR015615 | |
| Domain | PSI | 7.19e-04 | 32 | 103 | 3 | PF01437 | |
| Domain | IPT | 7.19e-04 | 32 | 103 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 7.19e-04 | 32 | 103 | 3 | IPR002165 | |
| Domain | TGFb_CS | 7.19e-04 | 32 | 103 | 3 | IPR017948 | |
| Domain | TGFB | 1.10e-03 | 37 | 103 | 3 | SM00204 | |
| Domain | TGF-b_C | 1.10e-03 | 37 | 103 | 3 | IPR001839 | |
| Domain | TGF_BETA_2 | 1.10e-03 | 37 | 103 | 3 | PS51362 | |
| Domain | TGF_beta | 1.10e-03 | 37 | 103 | 3 | PF00019 | |
| Domain | TGF_BETA_1 | 1.10e-03 | 37 | 103 | 3 | PS00250 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.39e-03 | 40 | 103 | 3 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.39e-03 | 40 | 103 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.39e-03 | 40 | 103 | 3 | PS50227 | |
| Domain | BAH | 1.60e-03 | 11 | 103 | 2 | SM00439 | |
| Domain | BAH | 1.60e-03 | 11 | 103 | 2 | PF01426 | |
| Domain | BAH | 1.60e-03 | 11 | 103 | 2 | PS51038 | |
| Domain | BAH_dom | 1.60e-03 | 11 | 103 | 2 | IPR001025 | |
| Domain | PSI | 1.83e-03 | 44 | 103 | 3 | IPR016201 | |
| Domain | PSI | 2.08e-03 | 46 | 103 | 3 | SM00423 | |
| Domain | Inhibin_asu | 2.26e-03 | 13 | 103 | 2 | IPR002405 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.65e-03 | 50 | 103 | 3 | PS00650 | |
| Domain | 7tm_2 | 2.65e-03 | 50 | 103 | 3 | PF00002 | |
| Domain | Diacylglycerol_kinase_cat_dom | 3.02e-03 | 15 | 103 | 2 | IPR001206 | |
| Domain | DAGK_cat | 3.02e-03 | 15 | 103 | 2 | PF00781 | |
| Domain | DAGK | 3.02e-03 | 15 | 103 | 2 | PS50146 | |
| Domain | Homeobox_KN | 3.88e-03 | 17 | 103 | 2 | PF05920 | |
| Domain | NAD/diacylglycerol_kinase | 3.88e-03 | 17 | 103 | 2 | IPR016064 | |
| Domain | Homeobox_KN_domain | 3.88e-03 | 17 | 103 | 2 | IPR008422 | |
| Domain | GPCR_2_secretin-like | 4.44e-03 | 60 | 103 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.44e-03 | 60 | 103 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.65e-03 | 61 | 103 | 3 | PS50261 | |
| Domain | - | 4.81e-03 | 283 | 103 | 6 | 1.10.10.60 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.84e-03 | 19 | 103 | 2 | IPR006553 | |
| Domain | LRR_CC | 4.84e-03 | 19 | 103 | 2 | SM00367 | |
| Domain | Semaphorin | 5.36e-03 | 20 | 103 | 2 | IPR027231 | |
| Domain | - | 6.04e-03 | 67 | 103 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 6.04e-03 | 67 | 103 | 3 | IPR029034 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 3.67e-05 | 76 | 70 | 5 | MM1433 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 4.99e-05 | 81 | 70 | 5 | M13863 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST | 5.11e-05 | 15 | 70 | 3 | M47824 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 1.26e-04 | 20 | 70 | 3 | M47843 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 2.20e-04 | 24 | 70 | 3 | MM1518 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 2.49e-04 | 25 | 70 | 3 | M984 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXQ1 UNCX YBX1 MYOD1 INSM1 GON4L RELA E4F1 CAMTA2 IRX3 MESP1 SKI RAX2 RFX2 IRX4 DMRTB1 ELK1 TAL1 | 3.53e-10 | 908 | 107 | 18 | 19274049 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C LONRF1 FBRSL1 MAML1 C15orf39 PLXND1 MBD6 IDUA ZZEF1 ADGRA2 ESRP2 GAS2L1 BMP8B TNRC18 SEC16A XXYLT1 WNK2 BAHCC1 | 7.65e-09 | 1105 | 107 | 18 | 35748872 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | ZNF703 SAMD1 FBRSL1 MAML1 GON4L C15orf39 NCKAP5L TNRC18 SEC16A ELK1 BAHCC1 | 4.46e-08 | 398 | 107 | 11 | 35016035 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ZC3H14 IRS4 SFSWAP YBX1 RELA IRX3 PPA1 NCKAP5L KHSRP AMOT SEC16A DLST MAP3K21 SDCBP VPS37D | 1.56e-07 | 922 | 107 | 15 | 27609421 |
| Pubmed | 5.62e-07 | 6 | 107 | 3 | 7605753 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | URI1 YBX1 FBRSL1 MAML1 C15orf39 POLR2M RELA NCKAP5L FRAT2 GLCCI1 MAP3K1 MEX3C RUSC2 SEC16A MAPK7 | 7.00e-07 | 1038 | 107 | 15 | 26673895 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.48e-06 | 351 | 107 | 9 | 38297188 | |
| Pubmed | ZNF703 IRS4 FOXQ1 YBX1 MYOD1 PEG10 FBRSL1 MAML1 GON4L C15orf39 RELA MBD6 SKI RFXAP SEC16A TRMT1L TAL1 | 1.73e-06 | 1429 | 107 | 17 | 35140242 | |
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 1460021 | ||
| Pubmed | 2.35e-06 | 9 | 107 | 3 | 21098559 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NR2E3 FOXQ1 CENPB MYOD1 MAML1 RELA E4F1 SKI RFX2 RFXAP ELK1 TAL1 SERTAD1 | 3.12e-06 | 877 | 107 | 13 | 20211142 |
| Pubmed | Bmp7 regulates germ cell proliferation in mouse fetal gonads. | 7.92e-06 | 13 | 107 | 3 | 18391523 | |
| Pubmed | 7.93e-06 | 152 | 107 | 6 | 38360978 | ||
| Pubmed | Integration of MAP kinase signal transduction pathways at the serum response element. | 9.38e-06 | 2 | 107 | 2 | 7618106 | |
| Pubmed | Activation of a muscle-specific enhancer by the Ski proto-oncogene. | 9.38e-06 | 2 | 107 | 2 | 7659522 | |
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 9463357 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 8682296 | ||
| Pubmed | 9.38e-06 | 2 | 107 | 2 | 21277400 | ||
| Pubmed | Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway. | 9.38e-06 | 2 | 107 | 2 | 31940275 | |
| Pubmed | Critical role of phosphorylation of serine 165 of YBX1 on the activation of NF-κB in colon cancer. | 9.38e-06 | 2 | 107 | 2 | 26318844 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SAMD1 FOXQ1 CENPB MAML1 RELA E4F1 SKI RFX2 KHSRP ESRP2 TRMT1L ZNF598 | 1.35e-05 | 857 | 107 | 12 | 25609649 |
| Pubmed | 2.65e-05 | 19 | 107 | 3 | 11562355 | ||
| Pubmed | Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. | 2.81e-05 | 3 | 107 | 2 | 17452529 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 38102140 | ||
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 9076678 | ||
| Pubmed | Cooperative Mesp activity is required for normal somitogenesis along the anterior-posterior axis. | 2.81e-05 | 3 | 107 | 2 | 16996494 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 10764802 | ||
| Pubmed | Requirement of Bmp8b for the generation of primordial germ cells in the mouse. | 2.81e-05 | 3 | 107 | 2 | 10894154 | |
| Pubmed | BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. | 2.81e-05 | 3 | 107 | 2 | 22579288 | |
| Pubmed | Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis. | 2.81e-05 | 3 | 107 | 2 | 11784057 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 30608580 | ||
| Pubmed | Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a. | 2.81e-05 | 3 | 107 | 2 | 25451979 | |
| Pubmed | Bone Morphogenetic Protein (BMP) signaling in development and human diseases. | 2.81e-05 | 3 | 107 | 2 | 25401122 | |
| Pubmed | Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). | 2.81e-05 | 3 | 107 | 2 | 12925636 | |
| Pubmed | c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases. | 2.81e-05 | 3 | 107 | 2 | 17352741 | |
| Pubmed | 2.81e-05 | 3 | 107 | 2 | 27611768 | ||
| Pubmed | 3.39e-05 | 399 | 107 | 8 | 35987950 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 3.62e-05 | 21 | 107 | 3 | 36240771 | |
| Pubmed | 3.62e-05 | 21 | 107 | 3 | 27894818 | ||
| Pubmed | 3.91e-05 | 122 | 107 | 5 | 36929488 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 15890200 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 21048223 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 20484977 | ||
| Pubmed | The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. | 5.60e-05 | 4 | 107 | 2 | 15029197 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 9434160 | ||
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 8843393 | ||
| Pubmed | Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation. | 5.60e-05 | 4 | 107 | 2 | 12878610 | |
| Pubmed | Determinants of helix-loop-helix dimerization affinity. Random mutational analysis of SCL/tal. | 5.60e-05 | 4 | 107 | 2 | 8576241 | |
| Pubmed | 5.60e-05 | 4 | 107 | 2 | 10072431 | ||
| Pubmed | MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms. | 5.60e-05 | 4 | 107 | 2 | 34325487 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.74e-05 | 430 | 107 | 8 | 35044719 | |
| Pubmed | 6.28e-05 | 69 | 107 | 4 | 30352686 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 6.46e-05 | 322 | 107 | 7 | 39098523 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | IRS4 NCKAP5L GLCCI1 MEX3C RUSC2 AMOT SEC16A NHS MAP3K21 ZNF598 PALLD | 7.18e-05 | 861 | 107 | 11 | 36931259 |
| Pubmed | Notch signaling is essential for ventricular chamber development. | 7.85e-05 | 27 | 107 | 3 | 17336907 | |
| Pubmed | Numb family proteins are essential for cardiac morphogenesis and progenitor differentiation. | 7.85e-05 | 27 | 107 | 3 | 24335256 | |
| Pubmed | Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation. | 9.32e-05 | 5 | 107 | 2 | 18513743 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 8573720 | ||
| Pubmed | RFP represses transcriptional activation by bHLH transcription factors. | 9.32e-05 | 5 | 107 | 2 | 16007160 | |
| Pubmed | MyoD enhances BMP7-induced osteogenic differentiation of myogenic cell cultures. | 9.32e-05 | 5 | 107 | 2 | 15020674 | |
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 11335133 | ||
| Pubmed | 9.32e-05 | 5 | 107 | 2 | 15677726 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 18521091 | ||
| Pubmed | MAP3K4 kinase activity dependent control of mouse gonadal sex determination†. | 1.40e-04 | 6 | 107 | 2 | 33912929 | |
| Pubmed | Comparison of Iroquois gene expression in limbs/fins of vertebrate embryos. | 1.40e-04 | 6 | 107 | 2 | 20408909 | |
| Pubmed | Clonal analysis reveals a common origin between nonsomite-derived neck muscles and heart myocardium. | 1.40e-04 | 6 | 107 | 2 | 25605943 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 11042145 | ||
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 9878243 | ||
| Pubmed | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation. | 1.40e-04 | 6 | 107 | 2 | 21152872 | |
| Pubmed | 1.40e-04 | 6 | 107 | 2 | 36773339 | ||
| Pubmed | Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. | 1.40e-04 | 6 | 107 | 2 | 10370142 | |
| Pubmed | SFSWAP YBX1 SCARF2 EGLN1 MAML1 RELA PLXND1 AMOT SEC16A HSPB1 | 1.46e-04 | 777 | 107 | 10 | 35844135 | |
| Pubmed | 1.88e-04 | 36 | 107 | 3 | 27606604 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 17681137 | ||
| Pubmed | A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. | 1.95e-04 | 7 | 107 | 2 | 14586460 | |
| Pubmed | The prepattern transcription factor Irx3 directs nephron segment identity. | 1.95e-04 | 7 | 107 | 2 | 17875669 | |
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 9070944 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 15124025 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 14499342 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 22835547 | ||
| Pubmed | 1.95e-04 | 7 | 107 | 2 | 12107726 | ||
| Pubmed | 1.96e-04 | 655 | 107 | 9 | 35819319 | ||
| Pubmed | 2.37e-04 | 529 | 107 | 8 | 14621295 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 2.44e-04 | 180 | 107 | 5 | 35198878 | |
| Pubmed | Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. | 2.59e-04 | 8 | 107 | 2 | 21224256 | |
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 18187455 | ||
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 32371981 | ||
| Pubmed | Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. | 2.59e-04 | 8 | 107 | 2 | 11160153 | |
| Pubmed | BRACHYURY directs histone acetylation to target loci during mesoderm development. | 2.59e-04 | 8 | 107 | 2 | 29141987 | |
| Pubmed | A Novel and Multivalent Role of Pax6 in Cerebellar Development. | 2.59e-04 | 8 | 107 | 2 | 27581449 | |
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 10231856 | ||
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 24742196 | ||
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 11118473 | ||
| Pubmed | Uncx4.1 is required for the formation of the pedicles and proximal ribs and acts upstream of Pax9. | 2.59e-04 | 8 | 107 | 2 | 10804168 | |
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 19956724 | ||
| Pubmed | 2.59e-04 | 8 | 107 | 2 | 33568778 | ||
| Pubmed | Uncoupling of chondrocyte death and vascular invasion in mouse galectin 3 null mutant bones. | 2.59e-04 | 8 | 107 | 2 | 11133164 | |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 2.77e-04 | 41 | 107 | 3 | 20431927 | |
| Pubmed | 3.20e-04 | 418 | 107 | 7 | 34709266 | ||
| Pubmed | Pitx2 promotes development of splanchnic mesoderm-derived branchiomeric muscle. | 3.33e-04 | 9 | 107 | 2 | 17107996 | |
| Interaction | CRX interactions | NR2E3 LONRF1 FBRSL1 MAML1 C15orf39 SKI RAX2 TNRC18 SDCBP BAHCC1 | 8.56e-07 | 254 | 105 | 10 | int:CRX |
| Interaction | TOP3B interactions | SEMA6C YBX1 LONRF1 FBRSL1 MAML1 C15orf39 PLXND1 MBD6 IDUA ZZEF1 ADGRA2 FBXL6 ESRP2 GAS2L1 BMP8B TNRC18 SEC16A XXYLT1 DLST ZNF598 WNK2 BAHCC1 | 5.66e-06 | 1470 | 105 | 22 | int:TOP3B |
| Interaction | BAG2 interactions | USP49 ZNF703 C15orf39 RELA FBXL6 ESRP2 AMOT DLST ELK1 MAPK7 ZNF598 PALLD HSPB1 | 2.10e-05 | 622 | 105 | 13 | int:BAG2 |
| Interaction | TNIP2 interactions | ZC3H14 IRS4 SFSWAP YBX1 RELA IRX3 PPA1 NCKAP5L KHSRP AMOT SEC16A DLST MAP3K21 ZNF598 SDCBP VPS37D | 3.26e-05 | 952 | 105 | 16 | int:TNIP2 |
| GeneFamily | Bone morphogenetic proteins|Astacins | 7.51e-06 | 11 | 66 | 3 | 455 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 8.90e-05 | 24 | 66 | 3 | 654 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.39e-03 | 20 | 66 | 2 | 736 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.64e-03 | 21 | 66 | 2 | 558 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 4.03e-03 | 26 | 66 | 2 | 526 | |
| Coexpression | E2F3_UP.V1_UP | CDKN1C ZNF703 SAMD1 PEG10 EGLN1 PLXND1 CDRT15 FBXL16 MAP3K21 | 8.89e-08 | 190 | 107 | 9 | M2706 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE | ZNF703 SAMD1 MBD6 PPM1J RFX2 ADGRA2 KHSRP XXYLT1 MAPK7 MAP3K21 SDCBP BAHCC1 | 2.24e-07 | 435 | 107 | 12 | M41115 |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | ZNF703 GGN LONRF1 AFF3 C15orf39 PLXND1 PPM1J ADGRA2 KHSRP RUSC2 BMP8B TNRC18 XXYLT1 NHS MAPK7 SDCBP BAHCC1 | 1.22e-05 | 1250 | 107 | 17 | M41099 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | CERKL REM1 SCARF2 MYOD1 FBRSL1 PPM1J IRX4 ESRP2 BMP8B FAM110C DOC2B | 1.43e-05 | 544 | 107 | 11 | M1936 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.63e-05 | 272 | 107 | 8 | M1938 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | ZNF703 IRS4 SCARF2 GGN MYOD1 INSM1 IRX3 MESP1 ADGRA2 IRX4 AMOT NHS DGKI BMP8A TAL1 | 2.02e-05 | 1035 | 107 | 15 | M9898 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 2.11e-05 | 282 | 107 | 8 | MM822 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | CERKL REM1 SCARF2 MYOD1 FBRSL1 PPM1J IRX4 ESRP2 BMP8B FAM110C DOC2B | 2.35e-05 | 574 | 107 | 11 | MM820 |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | 6.57e-05 | 244 | 107 | 7 | M9945 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | ZNF703 AFF3 IRX4 MAP3K1 MEX3C FBXL6 BMP8B SEMA3B PALLD HSPB1 | 6.80e-05 | 534 | 107 | 10 | M12522 |
| Coexpression | BILD_E2F3_ONCOGENIC_SIGNATURE | 7.28e-05 | 248 | 107 | 7 | M13061 | |
| Coexpression | GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 7.65e-05 | 172 | 107 | 6 | M9099 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP | 8.15e-05 | 174 | 107 | 6 | M6817 | |
| Coexpression | BENPORATH_EED_TARGETS | VGF URI1 DRD4 FOXQ1 MYOD1 IRX3 PLXND1 MESP1 IRX4 BMP6 AMOT DGKI BMP8A TAL1 | 1.04e-04 | 1059 | 107 | 14 | M7617 |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-06 | 172 | 107 | 6 | 1a9b99c7fc297d9e4b6098bf0c4fb98927a05f6d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-thrombocytic-platelet|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.76e-06 | 172 | 107 | 6 | d588ca825ab301910c1378e009b766c809b0bd5e | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.57e-06 | 178 | 107 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-06 | 179 | 107 | 6 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 185 | 107 | 6 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 193 | 107 | 6 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-06 | 199 | 107 | 6 | 74fe1737a0d63ef0bc49312f1b5823b5c39590dd | |
| ToppCell | medial-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-06 | 199 | 107 | 6 | 8ce0bcc53b3a955285d614459e45210104a6ed02 | |
| ToppCell | medial-mesenchymal-Vascular_Smooth_Muscle-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.66e-06 | 199 | 107 | 6 | 263603264ff40ea8ef569cb43f8b84b5938438ab | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 119 | 107 | 5 | e868453c02dcf0e07821886b81ca739887d43c67 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-05 | 66 | 107 | 4 | d5e878ffc0b942a35391c7dd73b30cec59f21b39 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e-Inhibitory_Neuron.Gad1Gad2.Sema3e-Kcng4_(GABAergic,_K_Channel_State,_Sema3e+_SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-05 | 66 | 107 | 4 | fdb695bbda639112c2f7b714adb7501aef4be19e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)-Sema3e|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-05 | 66 | 107 | 4 | de909119de42711b6580274b1200c0e1c6ad2f55 | |
| ToppCell | Severe-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.65e-05 | 145 | 107 | 5 | a24cad86509208bc7267b02ef1d1b0a25a2a7043 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-05 | 145 | 107 | 5 | 2eebf2294c53f081d3b0169071388e477a195218 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.76e-05 | 156 | 107 | 5 | b464871ad7c8ce0d58013a27996639eac1e526d8 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 161 | 107 | 5 | 8ec923c230a7a3cce5edf2a736b3a00d607c698a | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 4.77e-05 | 164 | 107 | 5 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 4.77e-05 | 164 | 107 | 5 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-05 | 166 | 107 | 5 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.20e-05 | 167 | 107 | 5 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | d6ad3b637de2935c656aad47ad82d6e8a8bd1227 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | 60ef186518d0dc63dbded2a77c65cfe3129df754 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-05 | 169 | 107 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 169 | 107 | 5 | 6ff1172da690ca17f7108f1617b255b766971a57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-05 | 174 | 107 | 5 | 66a3b20ff1ab9f36fb391986444d7dc99d0c03d1 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.84e-05 | 177 | 107 | 5 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.84e-05 | 177 | 107 | 5 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | IIF-Other-Platelet|IIF / Disease, Lineage and Cell Type | 7.03e-05 | 178 | 107 | 5 | 529c0d2159e539546876246122f2e999170a6b20 | |
| ToppCell | Endothelial|World / shred by cell class for turbinate | 7.22e-05 | 179 | 107 | 5 | 052b2681974be00efb8503fa4e2c85d91d5ebd06 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 107 | 5 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-05 | 180 | 107 | 5 | 81d60f0fa9e3b5bfcec85139a0a49e9130145f0e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 180 | 107 | 5 | 6b1606238417490e0d9930870a7827419d1c3737 | |
| ToppCell | Influenza_Severe-Platelet|World / Disease group and Cell class | 7.61e-05 | 181 | 107 | 5 | 5cdf935a89440114a58fa2042c1daed740d91c00 | |
| ToppCell | Influenza_Severe-Platelet|Influenza_Severe / Disease group and Cell class | 7.61e-05 | 181 | 107 | 5 | 4d037b098bb6f780ed8b15c0ec23a6f4d86bf45a | |
| ToppCell | severe_influenza-Platelet|severe_influenza / disease group, cell group and cell class (v2) | 7.81e-05 | 182 | 107 | 5 | 2018b71ec26bf3cd7ecdc04d5473900a697cd58a | |
| ToppCell | remission-Platelet|remission / disease stage, cell group and cell class | 7.81e-05 | 182 | 107 | 5 | 65e2798aacd670cbc3a8c8e9d1a2f7768513bb70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.01e-05 | 183 | 107 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 185 | 107 | 5 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.43e-05 | 185 | 107 | 5 | c95c77d4302d7fff7fdef1774f15a93ba9ced61a | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.43e-05 | 185 | 107 | 5 | 72a281ef246de5b30de1241d792c25bfae60e797 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.65e-05 | 186 | 107 | 5 | 3bf38c80d892a73391009b426dec8ae26a027351 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.65e-05 | 186 | 107 | 5 | 107bc473f5e57238390f8e0ab9f7263a8f93948c | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.65e-05 | 186 | 107 | 5 | 7496137cebc191aecd1e6ae7fa33118b128fbfe6 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.65e-05 | 186 | 107 | 5 | 9c2fd0bbc968c317a763f52e72fa7182c3c49850 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.65e-05 | 186 | 107 | 5 | 13a9ddcf93b0c4319ab9d484af5e2056e9754caa | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.65e-05 | 186 | 107 | 5 | 06281df5e9665ccc510279bf7e552845c63d5dab | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 8.65e-05 | 186 | 107 | 5 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | severe-Others|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.65e-05 | 186 | 107 | 5 | 234a4bc7c3529daf8804f2a366887d02a47075cd | |
| ToppCell | severe-Others-Megakaryocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.87e-05 | 187 | 107 | 5 | ef16331d1e5abe6bde7f09793c4a87a6ac24e592 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 187 | 107 | 5 | 08f2ecce3c08f35d995187b21bb7407a99dee4c2 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial-epithelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 187 | 107 | 5 | 939a068ac0913b9eeb5da4a9cb267d51cb711999 | |
| ToppCell | Control-Hematopoietic_Mega-Platelet|Control / Disease group, lineage and cell class | 8.87e-05 | 187 | 107 | 5 | 53e9665e1feb02ce8fe78ff4128fd4beacef8471 | |
| ToppCell | facs-SCAT-Fat-3m-Epithelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.87e-05 | 187 | 107 | 5 | e02e7f608506b9a48384f07727944f1cb8f7c575 | |
| ToppCell | Control-Hematopoietic_Mega|Control / Disease group, lineage and cell class | 8.87e-05 | 187 | 107 | 5 | 7bf98bdc83feb3918dbcf12e87a64fe4d2d41eba | |
| ToppCell | Healthy_donor-Platelet|Healthy_donor / disease group, cell group and cell class (v2) | 8.87e-05 | 187 | 107 | 5 | 9040ffa5c23913b9dc0205fa6227223c2a2847ae | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-05 | 188 | 107 | 5 | ca3be1942b179b512ab242acded31f1e3748c753 | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.09e-05 | 188 | 107 | 5 | e3d9919eafc6181d2145b9d36f47066d0e22a8bd | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-epi-tip_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.09e-05 | 188 | 107 | 5 | eefd2930833d216efbd72f67541bb2d9e7d47f3b | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.09e-05 | 188 | 107 | 5 | 6bd9317be8918da639254f4bdd432647c43ba9b1 | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 9.09e-05 | 188 | 107 | 5 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | 92319bef1f00d6048ba8f9f8b5c6dbb896686b74 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.56e-05 | 190 | 107 | 5 | 726aeb280ea911f3551b18e388c4f7580ae2ea74 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.56e-05 | 190 | 107 | 5 | 50ea3ff7ba1ca335b4e4538fae5f9b74b1fc10f7 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.56e-05 | 190 | 107 | 5 | a1f8757dc719ed030f67d65735358a8d7a407bad | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.56e-05 | 190 | 107 | 5 | c4f55f5a0c42aeb571791925ea80e02fac320608 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.80e-05 | 191 | 107 | 5 | a05e9a7eb137d804570dd7d8905975d735738767 | |
| ToppCell | COVID-19_Mild-Hematopoietic_Mega-Platelet|COVID-19_Mild / Disease group, lineage and cell class | 9.80e-05 | 191 | 107 | 5 | 6b3cfc670f69ed3e757cbf7498943e549e31326e | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 9.80e-05 | 191 | 107 | 5 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | Healthy_donor-Platelet|World / disease group, cell group and cell class (v2) | 9.80e-05 | 191 | 107 | 5 | defae87313d6345e3f451250fd66fe8831bb441c | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-04 | 192 | 107 | 5 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.03e-04 | 193 | 107 | 5 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.03e-04 | 193 | 107 | 5 | 9b97a7e9b5c1cc5db353070af0b9c5059714724b | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 1.03e-04 | 193 | 107 | 5 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | COVID-19-Myeloid-DC2|Myeloid / Condition, Lineage and Cell class | 1.03e-04 | 193 | 107 | 5 | 5f3f6db3d3de887d004662d229f42549601efa81 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-04 | 194 | 107 | 5 | 7c38ead538695db1fb1c329ff67d2874aa83c8d2 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-thrombocytic-platelet|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.05e-04 | 194 | 107 | 5 | 4531639974e363a6ff7ea688325a11407c3efd87 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-04 | 195 | 107 | 5 | 309c02ab7612687bdae3f12a60ebd4fb5839496e | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.08e-04 | 195 | 107 | 5 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.08e-04 | 195 | 107 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.11e-04 | 196 | 107 | 5 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 196 | 107 | 5 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-04 | 198 | 107 | 5 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-SCGB3A2+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.16e-04 | 198 | 107 | 5 | 1fe51f4beca0eef4ff117e6edaa646e35c0f9629 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | ef1a0c278c23614fd6a3218a9733abe6ecd6f686 | |
| ToppCell | Control-Control-Others|Control / Disease, condition lineage and cell class | 1.19e-04 | 199 | 107 | 5 | b7e83772fdd466e1bd0ae13af9ac477e7595ae14 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 199 | 107 | 5 | e6715288a586631676722f2323f0d833431161cf | |
| ToppCell | MS-IIF-Others-Platelet|IIF / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | 2254319216f1c2e0a0f015ea530c1e6a55a92d5d | |
| ToppCell | COVID-19-COVID-19_Mild-Others|COVID-19_Mild / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | ecf94be4bb961ec343471547f2ea327bc6f709f4 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-Platelet|COVID-19_Mild / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | bf5e7a36d6ed44a30f906702b40ace3ecd423398 | |
| ToppCell | Control|World / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | fb10b7fa85bc7d118e481a091645f1f523d29e25 | |
| ToppCell | Control-Control-Others-Platelet|Control / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | e0463c93714ab5fd00f294cca83bd61027fe0e95 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-Platelet|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | 5547e7173293fce403706f69331ce3976da73a32 | |
| ToppCell | Influenza-Influenza_Severe-Others-Platelet|Influenza_Severe / Disease, condition lineage and cell class | 1.22e-04 | 200 | 107 | 5 | 548e8e2f0e4225827db58b0c8b05221f18ae482b | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 115 | 107 | 4 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 3.31e-06 | 194 | 105 | 8 | 3969_DN | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.04e-04 | 26 | 104 | 3 | DOID:9351 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 1.17e-04 | 215 | 104 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | response to iloperidone | 1.83e-04 | 6 | 104 | 2 | GO_0036287 | |
| Disease | atrial fibrillation | 3.51e-04 | 371 | 104 | 7 | EFO_0000275 | |
| Disease | neuroimaging measurement | AFF3 PLXND1 MBD6 IDUA GLCCI1 MAP3K1 BMP6 ZNF469 DGKI DLST WNK2 BAHCC1 | 3.88e-04 | 1069 | 104 | 12 | EFO_0004346 |
| Disease | Endometrial Neoplasms | 1.14e-03 | 58 | 104 | 3 | C0014170 | |
| Disease | Malignant neoplasm of breast | UTS2R FOXQ1 YBX1 SCARF2 MYOD1 RELA PPA1 RFX2 MAP3K1 NHS SPOCD1 | 1.44e-03 | 1074 | 104 | 11 | C0006142 |
| Disease | Neoplasms, Experimental | 1.66e-03 | 66 | 104 | 3 | C0027659 | |
| Disease | Colonic Neoplasms | 2.09e-03 | 152 | 104 | 4 | C0009375 | |
| Disease | Endometrial Carcinoma | 2.13e-03 | 72 | 104 | 3 | C0476089 | |
| Disease | Malignant tumor of colon | 2.46e-03 | 159 | 104 | 4 | C0007102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVPCAPAENAPAPAR | 566 | P51826 | |
| LELPRRAFPAAAPAP | 901 | Q9HCM7 | |
| LARTPPAAAALGAPP | 986 | Q9HCM7 | |
| AAARLAPAGPAAQPP | 26 | Q9P281 | |
| APALVPVPAPAAAQA | 981 | Q4VCS5 | |
| RCSDAPPRASALPAP | 141 | P09564 | |
| PDPPAASALPAALAV | 171 | P09564 | |
| RPAVVLPSAAPAGAA | 176 | P19419 | |
| APHAPPRALPAAAED | 1091 | Q96PE1 | |
| AAALEPQAAARGPPP | 416 | O94983 | |
| PPAAAAPAEQAPRAK | 111 | Q86VQ1 | |
| RSEAAAAPAPAPAPT | 86 | Q8N531 | |
| APLPALSPAALSPAA | 671 | P78312 | |
| AAPRLPEAPALPFAR | 96 | Q96IS3 | |
| PLDSCPLLAPPEASA | 271 | Q9Y5X4 | |
| PALAPASLPARVSCP | 1076 | O95153 | |
| ARAFPPAVPQDAPAA | 486 | P78413 | |
| PCAEVRALPAPAAEP | 91 | Q96T59 | |
| TAPAPAAPAPRLDAA | 81 | Q92585 | |
| ARPAAPALTSVPAPA | 576 | Q13164 | |
| VLPSARLAEPPPDLA | 1311 | Q96JQ0 | |
| ALEPEPARPPLSALA | 821 | Q96DN6 | |
| AAPPPALDALSPFLR | 171 | Q9HCH0 | |
| APRPPPLAAAIAASD | 176 | Q17RB8 | |
| ISAVAVRFPPAAPPA | 156 | Q9Y4D7 | |
| APALLLADVPSESPP | 266 | P15172 | |
| LRGAAAAAAPPPPIE | 61 | Q86TG7 | |
| RPLPPAAIESPAVAA | 56 | P04792 | |
| ADTPAKRPLAAPSAP | 121 | A6NEQ2 | |
| LAPTAAPALPPALAA | 476 | Q86UU5 | |
| APALPPALAADQAPA | 481 | Q86UU5 | |
| PAARTPDSEVAPAAP | 21 | Q7Z6J2 | |
| APPDAVRAAALPPQT | 311 | P21917 | |
| AAAPAAPPIAAEPAA | 121 | Q6MZM9 | |
| APPIAAEPAAAAPLT | 126 | Q6MZM9 | |
| AAFLSALLPSQPPPA | 851 | Q8WX93 | |
| AAAPKAEPTAAAVPP | 161 | P36957 | |
| AAPRTPAAPASPAAV | 146 | P07199 | |
| RAAAPPDAPARPAVA | 51 | Q14184 | |
| RAPESPPSADPALVA | 6 | Q6EEV4 | |
| APVAVAVLAPAPAPA | 171 | P49918 | |
| AAAAPAPVPVPAASL | 81 | Q96MA1 | |
| LPLPAARGPARAPAA | 11 | O75912 | |
| RELRAAPPAPNAPAA | 166 | Q99501 | |
| LPLRAGPAAAAPETP | 151 | F2Z333 | |
| FESPAALPAVPPEAR | 1066 | Q3T8J9 | |
| PLRPPLPAAAAAAAG | 26 | P22004 | |
| RAPPAASRLPASAPL | 61 | Q7Z5Y6 | |
| APPEAAAVPPALLTS | 21 | Q49MI3 | |
| PPADPAAAASPCRAA | 116 | Q9GZT9 | |
| SLLAAPPVAPAEAPH | 16 | P35475 | |
| AAEDPVAAAPRPLPA | 506 | P35475 | |
| PDAARAIVDALPPPC | 256 | Q15181 | |
| ACQRAPPEALPATPA | 81 | Q66K89 | |
| RAPPAASRLPASAPL | 61 | P34820 | |
| DPAIPETPAPAARSA | 161 | Q1W6H9 | |
| PANPAILSEASAPIP | 26 | O00560 | |
| PPRAPRGAPAAAAAA | 111 | Q6SPF0 | |
| PAFPALLPAAPCRAL | 306 | Q9C009 | |
| PLAAAVPADKARPPA | 76 | O75474 | |
| AAKEPPAPRRPASLA | 251 | O75628 | |
| PAPAAARAPEPEAAA | 321 | Q01101 | |
| LDPCAPAPAPASALQ | 331 | P78415 | |
| AAAAAAAPEPPPRSR | 1206 | O14654 | |
| KRAPAAEPSPAAAPA | 146 | Q13233 | |
| AALVPPPAFAVTPAA | 6 | Q9Y6R4 | |
| PPPSLAAPLSRAALA | 56 | Q8N461 | |
| PPAPHDPSKAAAAAA | 556 | Q92945 | |
| PAPLAAPAAQVSVPA | 731 | Q8N2Y8 | |
| PSKQAAPRPAAPAAH | 871 | Q12872 | |
| SAPAPAPALAQAPAL | 51 | Q7Z2T5 | |
| SAPAPALVPLRAPDV | 16 | O94763 | |
| LLQALDRPASPPAPS | 86 | O15240 | |
| ALAAANAAPDPRAPG | 211 | Q5TCX8 | |
| RAAAPLSIAAPPLPA | 251 | Q6T4R5 | |
| PASVALRPSAAAPPV | 11 | P48378 | |
| LSPPALAAPAAPGRA | 121 | P17542 | |
| SPAEPGAPALRAPAA | 61 | Q5U5Q3 | |
| AASAPPAAAPEAPRS | 31 | Q5JR12 | |
| PAALAPAAAPTLAPA | 21 | O00287 | |
| PSSALLPAARVPAAP | 606 | Q9H6T0 | |
| RAAPEPRDPPALFAE | 211 | Q9BRJ9 | |
| DAAPIVSPLASPDPR | 156 | P0DKV0 | |
| PSPPAAPSVADNLLA | 91 | Q9UHV2 | |
| PGARALPSAVPDAAA | 516 | P12755 | |
| LPSAVPDAAAPADAP | 521 | P12755 | |
| RPFPAAAPAVAAAAP | 491 | P0C7V6 | |
| APAPAPAAAPALAAA | 506 | P0C7V6 | |
| PDPAALFSVAAPALP | 156 | Q7Z7M1 | |
| AAATSRAAPLAPLPA | 31 | Q8N7H1 | |
| LALPSPPAVAVASPA | 706 | Q6ZRI6 | |
| AAAAELPQARPLPSP | 1346 | O15417 | |
| PFAELPAPATSLAPA | 2411 | O15417 | |
| PAFPGRPRAAEPAAA | 566 | Q32MQ0 | |
| RPAVPAAVSLLPPAD | 26 | Q9H7S9 | |
| PAAPPAAPALSAADT | 11 | P67809 | |
| EPALAPADFVAPLAP | 2206 | O15027 | |
| LRAIAQAPPPPATAA | 261 | Q03431 | |
| LARAEEAAPAAPPGP | 671 | Q13214 | |
| ALSEAAPDPSLPPLA | 601 | Q96PX9 | |
| RLSSALAAPEPPGPA | 1181 | Q6ZMY3 | |
| LPEEATALAAPSPPR | 731 | Q96GP6 | |
| PRDAGPAASRPAALP | 216 | Q70CQ1 | |
| APARPALSAPAPRLG | 831 | Q9H3T2 | |
| AADPPKSFPAAAVLP | 186 | Q86XT2 | |
| ADPAPRVPRAAALPE | 1006 | Q96JG9 | |
| PPGALQAPEAPASRA | 611 | Q86UK7 | |
| PTDSLVLAPAAPARP | 366 | Q9UKP6 | |
| APALPPAAALLEPAR | 41 | O43149 | |
| AEAPLRLPAAPPLAF | 6 | Q8IYR6 | |
| GRPAAPAPAALVAQP | 91 | Q9Y3S1 | |
| SALAQAPAPVPVLAP | 401 | Q04206 | |
| EAAVPPLAIPSARPE | 111 | Q6PJT7 | |
| GAPAAPSPPALELAR | 61 | Q8NBI6 | |
| GAPAPAPAPFRDLAS | 451 | A6NJT0 |